Skip to main content
. 2018 May 2;40(1):61–72. doi: 10.3892/or.2018.6413

Figure 2.

Figure 2.

miR-125b inhibits ESCC cell proliferation. (A) EC109 and EC9706 cells transfected with miR-125b mimics or miR-125b inhibitors significantly increased or decreased, respectively, the expression of miR-125b compared with the control. (B) EC109 and EC9706 cells transfected with miR-125b mimics or miR-125b inhibitors both exhibited a significant decrease or increase, respectively, in the proliferation rate compared with the control. *P<0.05 vs. the control. ESCC, esophageal squamous cell carcinoma.